Henry Y. Huang

Associate

huang-henry-y-300
  • JD, Stanford Law School, 2007; with Distinction
  • AB (History and Science, Emphasis in Chemistry), magna cum laude, Harvard University, 2001

Qualifications

  • District of Columbia, 2011
  • California, 2007

Court Admissions

  • U.S. District Court for the Northern District of California, 2016
  • U.S. District Court for the District of Columbia, 2011
  • U.S. Court of Appeals for the Federal Circuit, 2010
  • Honorable Lucy Koh, U.S. District Court for the Northern District of California (2014)
  • Honorable Richard Linn, U.S. Court of Appeals for the Federal Circuit (2009 - 2010)
  • Washington, D.C. Super Lawyers (2014-2016)

Henry Y. Huang

Associate

Henry Huang joined Ropes & Gray in 2007 as an associate focusing on patent litigation. Henry has experience with multiple aspects of patent litigation, including initial assessment of claims and defenses, motions practice, electronic discovery, claim construction and Markman hearings, taking and defending depositions, and post-grant proceedings with the Patent and Trademark Office. His litigation experience includes oral argument at hearings before district courts and the Patent Trial and Appeal Board. Henry has also been involved in litigating trade dress and trade secret claims.

Prior to law school, Henry worked at Los Alamos National Laboratory in New Mexico, performing experiments in organic and environmental chemistry.  He has clerked for the Federal Circuit Court of Appeals and the Northern District of California.

Experience

  • Koios Pharmaceuticals v. Medac (PTAB): Represent patent owner in IPR proceeding relating to injectable methotrexate.
  • CPI Card Group, Inc. v. Multi Packaging Solutions, Inc. (D. Colo.): Represent defendant in patent litigation involving secure card packages.
  • Rovi v. Comcast et al. (PTAB): Represent Rovi in multiple IPR proceedings involving interactive program guides and related hardware and software.
  • Godo Kaisha IP Bridge 1 v. Broadcom Ltd et al. (E.D. Tex.): Represented IP Bridge in a multi-patent suit involving semiconductor fabrication and microprocessors.
  • CollabRx, Inc. v. The Jackson Laboratory (N.D. Cal.): Represented defendant in trade secret litigation involving cancer databases.
  • Leggett & Platt, Inc. v. Dreamwell, Ltd. (PTAB): Successfully defended patent owner against two IPR petitions by obtaining non-institution decisions on patents directed to micro-alloyed mattress springs.
  • Unified Messaging Solutions v. BB&T Corp. (N.D. Ill.): Represented BB&T in patent infringement litigation involving online messaging, including MDL proceedings.
  • Maxim Integrated Products v. BB&T Corp. (E.D.N.C., E.D. Tex., W.D. Pa.): Represented BB&T in patent infringement litigation involving mobile banking applications, including MDL proceedings.
  • Infinity Computer Products v. Ricoh Americas Corp. (E.D. Pa.): Represented Ricoh in patent infringement litigation involving multifunction printers, including co-pending ex parte reexaminations.
  • Smart Memory Solutions LLC v. Fujitsu Semiconductor Limited et al. (D. Del.) 1:11-cv-00680-LPS: Represented Fujitsu Semiconductor America and Fujitsu Semiconductor Limited in patent infringement litigation involving flash memory technology.
  • Advanced Data Access LLC v. Fujitsu Semiconductor Limited et al. (E.D. Tex.) 6:11-cv-00614-LED-JDL: Represented Fujitsu Semiconductor America and Fujitsu Semiconductor Limited in patent infringement litigation involving RAM technology.
  • Leveraged Innovations, LLC v. NASDAQ OMX Group, Inc., et al. (S.D.N.Y.) 1:11-cv-03203-KBF: Represented ProShare Advisors, LLC in patent infringement litigation involving leveraged exchange-traded products.
  • Sealy Tech. LLC v. Simmons Bedding Co. (M.D.N.C.) 1:10-cv-00702-JAB-JEP: Represented Simmons Bedding Company in patent and trade dress litigation involving mattress designs, including co-pending inter partes reexaminations.
  • Purdue Pharma Prods. L.P. v. Par Pharm., Inc. (D. Del.) No. 107-255-JJF: Represented Purdue Pharma Products in Hatch-Waxman patent litigation involving controlled-release tramadol.

Publications